Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
收藏Mendeley Data2024-06-19 更新2024-06-29 收录
下载链接：
https://gen3.biodatacatalyst.nhlbi.nih.gov/discovery/phs002909.v1.p1.c4/
下载链接
链接失效反馈官方服务：
资源简介：
Cohort Description The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) is a multi-center, observational, longitudinal case-control study designed to guide future development of therapies for COPD. SPIROMICS has recruited 2,983 COPD cases and controls, 40-80 years old with 20+ pack-years of smoking at 12 US sites in 2010–2015.
创建时间：
2024-06-13
